Parexel widens its eClinical program; Genae reaches into Dubai;

> Parexel ($PRXL) has expanded its roster of eClinical partners, integrating CRF Health and Clinical Ink into its Perceptive MyTrials partner program. More

> Belgian CRO Genae has opened clinical offices in Dubai, following a year full of expansion across Europe. News

> Contract drug developer ProBioGen is investing nearly $26 million to broaden its footprint and double its workforce. Story

Suggested Articles

Dubbed “Project Nightingale,” the efforts were announced amid concerns and federal inquiries into the data’s safekeeping and patient consent for use.

Independent site management organization Panthera Biopartners has kick-started its first clinical trial in the U.K.

WIRB-Copernicus Group’s clinical services division bought out trial consultancy firm Waife & Associates as it looks to boost its management services.